These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 38811527)
1. Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfection. Yang G; Cao J; Qin J; Mei X; Deng S; Xia Y; Zhao J; Wang J; Luan T; Chen D; Huang P; Chen C; Sun X; Luo Q; Su J; Zhang Y; Zhong N; Wang Z Signal Transduct Target Ther; 2024 May; 9(1):141. PubMed ID: 38811527 [TBL] [Abstract][Full Text] [Related]
2. Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques. Hasenkrug KJ; Feldmann F; Myers L; Santiago ML; Guo K; Barrett BS; Mickens KL; Carmody A; Okumura A; Rao D; Collins MM; Messer RJ; Lovaglio J; Shaia C; Rosenke R; van Doremalen N; Clancy C; Saturday G; Hanley P; Smith BJ; Meade-White K; Shupert WL; Hawman DW; Feldmann H mBio; 2021 Aug; 12(4):e0150321. PubMed ID: 34311582 [TBL] [Abstract][Full Text] [Related]
3. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460 [TBL] [Abstract][Full Text] [Related]
4. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection. Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP Nat Rev Immunol; 2021 Jun; 21(6):395-404. PubMed ID: 33927374 [TBL] [Abstract][Full Text] [Related]
6. Phenotypes and Functions of SARS-CoV-2-Reactive T Cells. Jung MK; Shin EC Mol Cells; 2021 Jun; 44(6):401-407. PubMed ID: 34120892 [TBL] [Abstract][Full Text] [Related]
7. Suboptimal SARS-CoV-2-specific CD8 Habel JR; Nguyen THO; van de Sandt CE; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Jia X; Chua B; Zhang W; Tan HX; Flanagan KL; Doolan DL; Torresi J; Chen W; Wakim LM; Cheng AC; Doherty PC; Petersen J; Rossjohn J; Wheatley AK; Kent SJ; Rowntree LC; Kedzierska K Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24384-24391. PubMed ID: 32913053 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay. Cassaniti I; Percivalle E; Bergami F; Piralla A; Comolli G; Bruno R; Vecchia M; Sambo M; Colaneri M; Zuccaro V; Benazzo M; Robotti C; Calastri A; Maiorano E; Ferrari A; Cambiè G; Baldanti F Clin Microbiol Infect; 2021 Jul; 27(7):1029-1034. PubMed ID: 33813122 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells. Jung JH; Rha MS; Sa M; Choi HK; Jeon JH; Seok H; Park DW; Park SH; Jeong HW; Choi WS; Shin EC Nat Commun; 2021 Jun; 12(1):4043. PubMed ID: 34193870 [TBL] [Abstract][Full Text] [Related]
10. Preschool-age children maintain a distinct memory CD4 Manfroi B; Cuc BT; Sokal A; Vandenberghe A; Temmam S; Attia M; El Behi M; Camaglia F; Nguyen NT; Pohar J; Salem-Wehbe L; Pottez-Jouatte V; Borzakian S; Elenga N; Galeotti C; Morelle G; de Truchis de Lays C; Semeraro M; Romain AS; Aubart M; Ouldali N; Mahuteau-Betzer F; Beauvineau C; Amouyal E; Berthaud R; Crétolle C; Arnould MD; Faye A; Lorrot M; Benoist G; Briand N; Courbebaisse M; Martin R; Van Endert P; Hulot JS; Blanchard A; Tartour E; Leite-de-Moraes M; Lezmi G; Ménager M; Luka M; Reynaud CA; Weill JC; Languille L; Michel M; Chappert P; Mora T; Walczak AM; Eloit M; Bacher P; Scheffold A; Mahévas M; Sermet-Gaudelus I; Fillatreau S Sci Transl Med; 2024 Sep; 16(765):eadl1997. PubMed ID: 39292802 [TBL] [Abstract][Full Text] [Related]
11. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19. Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525 [TBL] [Abstract][Full Text] [Related]
12. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents. Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P Front Immunol; 2021; 12():797919. PubMed ID: 34975908 [TBL] [Abstract][Full Text] [Related]
13. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension. Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y Front Immunol; 2020; 11():596684. PubMed ID: 33362779 [TBL] [Abstract][Full Text] [Related]
14. Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses. Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson SC; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer DE; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA; Cell Rep; 2022 Feb; 38(6):110345. PubMed ID: 35090598 [TBL] [Abstract][Full Text] [Related]
15. Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection. Ansari A; Arya R; Sachan S; Jha SN; Kalia A; Lall A; Sette A; Grifoni A; Weiskopf D; Coshic P; Sharma A; Gupta N Front Immunol; 2021; 12():636768. PubMed ID: 33777028 [TBL] [Abstract][Full Text] [Related]
16. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19. Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962 [TBL] [Abstract][Full Text] [Related]
17. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients. Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W Front Immunol; 2021; 12():684014. PubMed ID: 34194438 [TBL] [Abstract][Full Text] [Related]
18. Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection. Hou H; Zhang Y; Tang G; Luo Y; Liu W; Cheng C; Jiang Y; Xiong Z; Wu S; Sun Z; Xu S; Fan X; Wang F J Allergy Clin Immunol; 2021 Dec; 148(6):1481-1492.e2. PubMed ID: 34536418 [TBL] [Abstract][Full Text] [Related]
19. Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response up to 10 Months. Kaaijk P; Pimentel VO; Emmelot ME; Poelen MCM; Cevirgel A; Schepp RM; den Hartog G; Reukers DFM; Beckers L; van Beek J; van Els CACM; Meijer A; Rots NY; de Wit J Front Immunol; 2022; 13():817876. PubMed ID: 35197982 [TBL] [Abstract][Full Text] [Related]
20. High Frequencies of Functional Virus-Specific CD4 Mele D; Calastri A; Maiorano E; Cerino A; Sachs M; Oliviero B; Mantovani S; Baldanti F; Bruno R; Benazzo M; Grifoni A; Sette A; Mondelli MU; Varchetta S Front Immunol; 2021; 12():748881. PubMed ID: 34858405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]